TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -4 | -4 | 2 | -25 | -20 | 2 | -8 |
| S | %wins | 100 | 100 | 0 | 100 | 100 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/11 13:48 | 5/11/11 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Durham Mark Andrew | A6 | O | SVP HR | M.d | 1,225 | 24.50 | 33 | 50 | 431 | 62 | D | 411 | 233 | 103 | 27 | 4 | -1 | 7 | 0 | -4 | -4 | 2 | -25 | -20 | 2 |
5/13/11 13:48 | 5/11/11 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Durham Mark Andrew | A6 | O | SVP HR | S.d | -2,609 | 52.17 | 33 | -50 | -45 | 62 | D | 411 | 233 | 103 | 27 | 4 | -1 | 7 | 0 | -4 | -4 | 2 | -25 | -20 | 2 |
11/10/10 17:19 | 11/8/10 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Durham Mark Andrew | A6 | O | SVP,HR | M.d | 0 | 0.00 | 33 | 103 | 57 | D | 228 | 97 | 56 | 15 | 2 | -2 | -6 | -5 | -1 | -4 | 9 | 58 | 105 | 69 | |
8/20/10 14:49 | 8/20/10 | BVF | Biovail Corp | A6 | Health | Drug | Pharmaceutical Preparations | Durham Mark Andrew | A6 | O | SVP,HR,S | M.d | 1,020 | 17.00 | 0 | 60 | 1 | D | |||||||||||||||
8/20/10 14:49 | 8/20/10 | BVF | Biovail Corp | A6 | Health | Drug | Pharmaceutical Preparations | Durham Mark Andrew | A6 | O | SVP,HR,S | S.d | -1,336 | 22.26 | 0 | -60 | -98 | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |